KBI Biopharma

Getting through cell line development is an important milestone. But it’s not the finish line. At KBI Biopharma, our goal is to help promising molecules keep moving toward the clinic and, ultimately, reach the patients who need them. In this BioProcess International Theater Insider interview, Sigma Mostafa shares the thinking behind that commitment and why supporting customers beyond CLD matters. Watch the interview: https://hubs.la/Q04x8YB30 That same commitment is behind our CLD Rebate Program. Eligible programs can receive up to $500,000 toward their first GMP batch, helping reduce financial pressure at one of the most critical transitions in biologics development. If GMP is your next milestone, see how KBI can help you get there. Learn more: https://hubs.la/Q04x8YxV0 #CellLineDevelopment #CLD #Biologics #GMPManufacturing #CDMO #KBIBiopharma

Our CLD Rebate Program is live! Don’t let progress stall you. Let it reward you. Today we introduce the CLD Rebate Program, designed to help reduce financial pressure as biotech companies move from CLD to the first GMP batch. ➡️ Because development should do more than generate a result. ➡️ Because progress should be rewarded. ➡️ Because getting to clinic matters. And we believe the next step should be easier to reach. Up to $500K toward your first GMP batch. Reserve your slot today. 👉 https://lnkd.in/eqagmgVq

Behind every life-saving therapeutic is a complex, challenging journey from discovery to the clinic. But what if we could make that journey smoother, faster, and more predictable? At KBI Biopharma, our ultimate goal is to help accelerate the delivery of crucial treatments to the patients who need them most. On June 22nd, we are taking a massive step forward in that mission by unveiling a new initiative for integrated drug development. Join us at BIO International in San Diego (Booth #4235) to learn how we can support your pipeline or sign up to get notified of the official launch on June 22nd. 👉Sign up here to get notified: https://lnkd.in/et-g_Bp5

Join us in Basel for a Lunch & Learn on de-risking CMC! Register and see the agenda now: https://lnkd.in/eJRRNv7Y We are excited to invite our network in Europe to an exclusive KBI Biopharma Lunch & Learn. This is a great opportunity designed for biopharma leaders who need to accelerate development while de-risking CMC. 📅 Date: February 3, 2026 📍Location: Basel, Switzerland Space is limited, so secure your spot today!

Discover how KBI Biopharma collaborates closely with over +1400 global clients to deliver personalized solutions for their biopharmaceutical needs. We combine expertise and innovation to support your clinical and commercial production goals effectively.

KBI Biopharma is a leading global CDMO providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 1400+ customer partners, we work closely to personalize and accelerate drug development programs.